Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogenesis

Showing results (31-40 of 1,003) with videos related to

Pageof 101
Sort By:
Oncogenesis|March 13, 2021
EHF suppresses cancer progression by inhibiting ETS1-mediated ZEB expressionKaname Sakamoto, Kaori Endo, Kei Sakamoto, et al.
Oncogenesis|March 14, 2021
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancerFabiana Alejandra Rossi, Juliana Haydeé Enriqué Steinberg, Ezequiel Hernán Calvo Roitberg, et al.
Oncogenesis|December 11, 2021
Depletion of NK6 Homeobox 3 (NKX6.3) causes gastric carcinogenesis through copy number alterations by inducing impairment of DNA replication and repair regulationJung Hwan Yoon, Jung Woo Eun, Hassan Ashktorab, et al.
Oncogenesis|October 10, 2022
Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtypeXuming Song, Te Zhang, Hanlin Ding, et al.
Oncogenesis|September 8, 2015
FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppressionH Guan, P Tan, L Xie, et al.
Oncogenesis|December 16, 2014
Kinome-wide screening of HER2+ breast cancer cells for molecules that mediate cell proliferation or sensitize cells to trastuzumab therapyV Lapin, E A Shirdel, X Wei, et al.
Oncogenesis|January 26, 2016
Lipid metabolic reprogramming in cancer cellsS Beloribi-Djefaflia, S Vasseur, F Guillaumond
Oncogenesis|October 6, 2015
PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitorsS N Payne, M E Maher, N H Tran, et al.
Oncogenesis|April 5, 2016
The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situE S Papadakis, C R Barker, H Syed, et al.
Oncogenesis|March 22, 2016
Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cellsB I Bassey-Archibong, J M Kwiecien, S B Milosavljevic, et al.
Pageof 101

Showing results (31-40 of 1,003) with videos related to

Sort By:
Pageof 101
Oncogenesis|March 13, 2021
EHF suppresses cancer progression by inhibiting ETS1-mediated ZEB expressionKaname Sakamoto, Kaori Endo, Kei Sakamoto, et al.
Oncogenesis|March 14, 2021
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancerFabiana Alejandra Rossi, Juliana Haydeé Enriqué Steinberg, Ezequiel Hernán Calvo Roitberg, et al.
Oncogenesis|December 11, 2021
Depletion of NK6 Homeobox 3 (NKX6.3) causes gastric carcinogenesis through copy number alterations by inducing impairment of DNA replication and repair regulationJung Hwan Yoon, Jung Woo Eun, Hassan Ashktorab, et al.
Oncogenesis|October 10, 2022
Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtypeXuming Song, Te Zhang, Hanlin Ding, et al.
Oncogenesis|September 8, 2015
FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppressionH Guan, P Tan, L Xie, et al.
Oncogenesis|December 16, 2014
Kinome-wide screening of HER2+ breast cancer cells for molecules that mediate cell proliferation or sensitize cells to trastuzumab therapyV Lapin, E A Shirdel, X Wei, et al.
Oncogenesis|January 26, 2016
Lipid metabolic reprogramming in cancer cellsS Beloribi-Djefaflia, S Vasseur, F Guillaumond
Oncogenesis|October 6, 2015
PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitorsS N Payne, M E Maher, N H Tran, et al.
Oncogenesis|April 5, 2016
The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situE S Papadakis, C R Barker, H Syed, et al.
Oncogenesis|March 22, 2016
Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cellsB I Bassey-Archibong, J M Kwiecien, S B Milosavljevic, et al.
Pageof 101